Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis

Psoriasis is a complex chronic inflammatory cutaneous disorder. To date, robust molecular mechanisms of psoriasis have been reported. Among diverse aberrant immunopathogenetic mechanisms, the current model emphasizes the role of Th1 and the IL-23/Th17 axis, skin-resident immune cells and major signa...

Full description

Bibliographic Details
Main Authors: Yu Ri Woo, Dae Ho Cho, Hyun Jeong Park
Format: Article
Language:English
Published: MDPI AG 2017-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/18/12/2684
id doaj-871e3df9c10947a39f29efc9f13422af
record_format Article
spelling doaj-871e3df9c10947a39f29efc9f13422af2020-11-25T01:30:37ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-12-011812268410.3390/ijms18122684ijms18122684Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: PsoriasisYu Ri Woo0Dae Ho Cho1Hyun Jeong Park2Department of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, KoreaDepartment of Life Science, Sookmyung Women’s University, Seoul 04310, KoreaDepartment of Dermatology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, KoreaPsoriasis is a complex chronic inflammatory cutaneous disorder. To date, robust molecular mechanisms of psoriasis have been reported. Among diverse aberrant immunopathogenetic mechanisms, the current model emphasizes the role of Th1 and the IL-23/Th17 axis, skin-resident immune cells and major signal transduction pathways involved in psoriasis. The multiple genetic risk loci for psoriasis have been rapidly revealed with the advent of a novel technology. Moreover, identifying epigenetic modifications could bridge the gap between genetic and environmental risk factors in psoriasis. This review will provide a better understanding of the pathogenesis of psoriasis by unraveling the complicated interplay among immunological abnormalities, genetic risk foci, epigenetic modification and environmental factors of psoriasis. With advances in molecular biology, diverse new targets are under investigation to manage psoriasis. The recent advances in treatment modalities for psoriasis based on targeted molecules are also discussed.https://www.mdpi.com/1422-0067/18/12/2684biologicsepigeneticsgeneticsinterleukin-23psoriasissignaling pathwaysmall moleculesT helper 17 cells
collection DOAJ
language English
format Article
sources DOAJ
author Yu Ri Woo
Dae Ho Cho
Hyun Jeong Park
spellingShingle Yu Ri Woo
Dae Ho Cho
Hyun Jeong Park
Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
International Journal of Molecular Sciences
biologics
epigenetics
genetics
interleukin-23
psoriasis
signaling pathway
small molecules
T helper 17 cells
author_facet Yu Ri Woo
Dae Ho Cho
Hyun Jeong Park
author_sort Yu Ri Woo
title Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
title_short Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
title_full Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
title_fullStr Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
title_full_unstemmed Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
title_sort molecular mechanisms and management of a cutaneous inflammatory disorder: psoriasis
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2017-12-01
description Psoriasis is a complex chronic inflammatory cutaneous disorder. To date, robust molecular mechanisms of psoriasis have been reported. Among diverse aberrant immunopathogenetic mechanisms, the current model emphasizes the role of Th1 and the IL-23/Th17 axis, skin-resident immune cells and major signal transduction pathways involved in psoriasis. The multiple genetic risk loci for psoriasis have been rapidly revealed with the advent of a novel technology. Moreover, identifying epigenetic modifications could bridge the gap between genetic and environmental risk factors in psoriasis. This review will provide a better understanding of the pathogenesis of psoriasis by unraveling the complicated interplay among immunological abnormalities, genetic risk foci, epigenetic modification and environmental factors of psoriasis. With advances in molecular biology, diverse new targets are under investigation to manage psoriasis. The recent advances in treatment modalities for psoriasis based on targeted molecules are also discussed.
topic biologics
epigenetics
genetics
interleukin-23
psoriasis
signaling pathway
small molecules
T helper 17 cells
url https://www.mdpi.com/1422-0067/18/12/2684
work_keys_str_mv AT yuriwoo molecularmechanismsandmanagementofacutaneousinflammatorydisorderpsoriasis
AT daehocho molecularmechanismsandmanagementofacutaneousinflammatorydisorderpsoriasis
AT hyunjeongpark molecularmechanismsandmanagementofacutaneousinflammatorydisorderpsoriasis
_version_ 1725091081427615744